Deletion of MCL-1 sensitized the NPC cells to BCL-XL selective inhibitor A-1331852, suggesting that MCL-1 and BCL-XL may be important for NPC cell survival. This evidence concerns the gene BCL2L1 and nasopharyngeal carcinoma.